Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5492327 | 0.99 | RECQL (0.42) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL5483709 | 0.99 | RECQL (0.42) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL27547997 | 0.90 | DGKA (0.46) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL9157173 | 0.89 | DGKA (0.47) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL28399581 | 0.89 | DGKA (0.47) | RECQLDGKAMAPTLMNAALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL29037399 | 0.88 | DGKA (0.46) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL6270899 | 0.86 | DGKA (0.49) | RECQLDGKAMAPTLMNADUSP3 | |
| SCHEMBL5275136 | 0.86 | DGKA (0.49) | RECQLDGKAMAPTLMNADUSP3 | |
| SCHEMBL4959012 | 0.85 | RECQL (0.47) | RECQLDGKAMAPTLMNAALDH1A1 | |
| SCHEMBL27534701 | 0.84 | DGKA (0.50) | RECQLDGKAMAPTLMNADUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871330-A2 | HAIR TREATMENT COMPOSITIONS | Unilever Plc (GB) | 2008-01-02 | — | — | EP | disclosed |
| EP-1771148-B1 | MILD, MOISTURIZING SULFOSUCCINATE CLEANSING COMPOSITIONS | UNILEVER PLC (GB) | 2007-12-05 | — | — | EP | disclosed |
| EP-1771148-A1 | MILD, MOISTURIZING SULFOSUCCINATE CLEANSING COMPOSITIONS | Unilever Plc (GB) | 2007-04-11 | — | — | EP | disclosed |
| US-20060263319-A1 | HAIR TREATMENT COMPOSITIONS | CONOPCO, INC. D/B/A UNILEVER | 2006-11-23 | — | — | US | disclosed |
| WO-2006105939-A2 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2006-10-12 | — | — | WO | disclosed |
| US-7041627-B2 | Mild, moisturizing sulfosuccinate cleansing compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2006-05-09 | — | — | US | disclosed |
| US-20060019858-A1 | Mild, moisturizing sulfosuccinate cleansing compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2006-01-26 | — | — | US | disclosed |
| WO-2006007925-A1 | MILD, MOISTURIZING SULFOSUCCINATE CLEANSING COMPOSITIONS | UNILEVER PLC (GB) | 2006-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060263319-A1 | HAIR TREATMENT COMPOSITIONS | OTC, OAT, SLC25A20 | RECQL 3518/4885DGKA 2590/4885MAPT 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.